Annual EBITDA
-$46.23 M
-$16.06 M-53.21%
December 31, 2023
Summary
- As of February 7, 2025, CRMD annual EBITDA is -$46.23 million, with the most recent change of -$16.06 million (-53.21%) on December 31, 2023.
- During the last 3 years, CRMD annual EBITDA has fallen by -$19.20 million (-71.01%).
- CRMD annual EBITDA is now -1445.93% below its all-time high of -$2.99 million, reached on December 31, 2012.
Performance
CRMD EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$2.69 M
+$11.38 M+80.88%
September 30, 2024
Summary
- As of February 7, 2025, CRMD quarterly EBITDA is -$2.69 million, with the most recent change of +$11.38 million (+80.88%) on September 30, 2024.
- Over the past year, CRMD quarterly EBITDA has increased by +$12.04 million (+81.74%).
- CRMD quarterly EBITDA is now -176.63% below its all-time high of $3.51 million, reached on June 30, 2014.
Performance
CRMD Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$47.32 M
+$7.02 M+12.93%
September 30, 2024
Summary
- As of February 7, 2025, CRMD TTM EBITDA is -$47.32 million, with the most recent change of +$7.02 million (+12.93%) on September 30, 2024.
- Over the past year, CRMD TTM EBITDA has dropped by -$1.08 million (-2.34%).
- CRMD TTM EBITDA is now -7343.05% below its all-time high of -$635.70 thousand, reached on March 31, 2009.
Performance
CRMD TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CRMD EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -53.2% | +81.7% | -2.3% |
3 y3 years | -71.0% | +67.1% | -56.8% |
5 y5 years | -72.8% | +54.2% | -84.4% |
CRMD EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -57.4% | at low | at high | +83.0% | -62.1% | +12.9% |
5 y | 5-year | -124.1% | at low | at high | +83.0% | -129.3% | +12.9% |
alltime | all time | -1445.9% | at low | -176.6% | +83.9% | -7343.1% | +12.9% |
CorMedix EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$2.69 M(-80.9%) | -$47.32 M(-12.9%) |
Jun 2024 | - | -$14.07 M(-11.1%) | -$54.34 M(+5.5%) |
Mar 2024 | - | -$15.83 M(+7.5%) | -$51.52 M(+11.4%) |
Dec 2023 | -$46.23 M(+53.2%) | -$14.73 M(+51.6%) | -$46.23 M(+16.5%) |
Sep 2023 | - | -$9.71 M(-13.7%) | -$39.68 M(+7.9%) |
Jun 2023 | - | -$11.25 M(+6.7%) | -$36.79 M(+9.1%) |
Mar 2023 | - | -$10.54 M(+28.9%) | -$33.71 M(+11.7%) |
Dec 2022 | -$30.18 M(+2.7%) | -$8.18 M(+19.8%) | -$30.18 M(+1.4%) |
Sep 2022 | - | -$6.82 M(-16.4%) | -$29.76 M(-5.5%) |
Jun 2022 | - | -$8.17 M(+16.5%) | -$31.49 M(+7.9%) |
Mar 2022 | - | -$7.01 M(-9.7%) | -$29.19 M(-0.7%) |
Dec 2021 | -$29.38 M(+8.7%) | -$7.77 M(-9.1%) | -$29.38 M(+6.4%) |
Sep 2021 | - | -$8.55 M(+45.6%) | -$27.62 M(+7.7%) |
Jun 2021 | - | -$5.87 M(-18.5%) | -$25.65 M(-10.6%) |
Mar 2021 | - | -$7.20 M(+20.0%) | -$28.70 M(+6.2%) |
Dec 2020 | -$27.04 M(+31.0%) | -$6.00 M(-8.8%) | -$27.04 M(+2.7%) |
Sep 2020 | - | -$6.58 M(-26.2%) | -$26.32 M(+6.1%) |
Jun 2020 | - | -$8.92 M(+61.2%) | -$24.81 M(+16.4%) |
Mar 2020 | - | -$5.53 M(+4.8%) | -$21.32 M(+3.3%) |
Dec 2019 | -$20.63 M(-22.9%) | -$5.28 M(+4.0%) | -$20.63 M(+56.5%) |
Sep 2019 | - | -$5.08 M(-6.5%) | -$13.19 M(-28.1%) |
Jun 2019 | - | -$5.43 M(+12.1%) | -$18.33 M(-14.5%) |
Mar 2019 | - | -$4.85 M(-323.7%) | -$21.44 M(-19.9%) |
Dec 2018 | -$26.75 M(-18.8%) | $2.17 M(-121.2%) | -$26.75 M(-31.8%) |
Sep 2018 | - | -$10.22 M(+19.7%) | -$39.22 M(+0.7%) |
Jun 2018 | - | -$8.54 M(-16.0%) | -$38.94 M(+9.6%) |
Mar 2018 | - | -$10.16 M(-1.3%) | -$35.54 M(+7.8%) |
Dec 2017 | -$32.97 M(+33.9%) | -$10.30 M(+3.5%) | -$32.97 M(+13.4%) |
Sep 2017 | - | -$9.94 M(+93.6%) | -$29.06 M(+2.9%) |
Jun 2017 | - | -$5.14 M(-32.3%) | -$28.23 M(+0.9%) |
Mar 2017 | - | -$7.59 M(+18.7%) | -$27.98 M(+14.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2016 | -$24.62 M(+35.5%) | -$6.39 M(-29.9%) | -$24.50 M(+11.5%) |
Sep 2016 | - | -$9.12 M(+86.7%) | -$21.97 M(+25.3%) |
Jun 2016 | - | -$4.88 M(+18.7%) | -$17.54 M(+4.5%) |
Mar 2016 | - | -$4.11 M(+6.5%) | -$16.78 M(-7.6%) |
Dec 2015 | -$18.17 M(-11.1%) | -$3.86 M(-17.6%) | -$18.17 M(+10.0%) |
Sep 2015 | - | -$4.68 M(+13.5%) | -$16.51 M(-2.0%) |
Jun 2015 | - | -$4.13 M(-24.9%) | -$16.86 M(+82.9%) |
Mar 2015 | - | -$5.49 M(+148.6%) | -$9.22 M(-54.9%) |
Dec 2014 | -$20.44 M(+166.0%) | -$2.21 M(-56.0%) | -$20.43 M(-5.5%) |
Sep 2014 | - | -$5.02 M(-243.1%) | -$21.63 M(+15.1%) |
Jun 2014 | - | $3.51 M(-121.0%) | -$18.79 M(-20.3%) |
Mar 2014 | - | -$16.71 M(+391.3%) | -$23.59 M(+207.0%) |
Dec 2013 | -$7.68 M(+156.9%) | -$3.40 M(+55.5%) | -$7.68 M(+60.9%) |
Sep 2013 | - | -$2.19 M(+69.6%) | -$4.78 M(+33.5%) |
Jun 2013 | - | -$1.29 M(+59.9%) | -$3.58 M(+23.4%) |
Mar 2013 | - | -$806.10 K(+63.4%) | -$2.90 M(-3.0%) |
Dec 2012 | -$2.99 M(-58.2%) | -$493.20 K(-50.1%) | -$2.99 M(+14.7%) |
Sep 2012 | - | -$989.10 K(+61.8%) | -$2.61 M(-38.1%) |
Jun 2012 | - | -$611.20 K(-31.9%) | -$4.22 M(-30.6%) |
Mar 2012 | - | -$897.20 K(+712.7%) | -$6.08 M(-15.0%) |
Dec 2011 | -$7.15 M(-11.5%) | -$110.40 K(-95.7%) | -$7.15 M(-22.2%) |
Sep 2011 | - | -$2.60 M(+5.0%) | -$9.19 M(+15.1%) |
Jun 2011 | - | -$2.47 M(+25.5%) | -$7.99 M(+19.5%) |
Mar 2011 | - | -$1.97 M(-8.3%) | -$6.68 M(-17.3%) |
Dec 2010 | -$8.08 M(+33.7%) | -$2.15 M(+54.7%) | -$8.08 M(-18.4%) |
Sep 2010 | - | -$1.39 M(+18.8%) | -$9.90 M(+6.2%) |
Jun 2010 | - | -$1.17 M(-65.3%) | -$9.32 M(+6.1%) |
Mar 2010 | - | -$3.37 M(-15.0%) | -$8.78 M(+45.3%) |
Dec 2009 | -$6.04 M | -$3.97 M(+388.9%) | -$6.04 M(+190.9%) |
Sep 2009 | - | -$811.30 K(+28.8%) | -$2.08 M(+64.1%) |
Jun 2009 | - | -$630.10 K(-0.9%) | -$1.27 M(+99.1%) |
Mar 2009 | - | -$635.70 K | -$635.70 K |
FAQ
- What is CorMedix annual EBITDA?
- What is the all time high annual EBITDA for CorMedix?
- What is CorMedix annual EBITDA year-on-year change?
- What is CorMedix quarterly EBITDA?
- What is the all time high quarterly EBITDA for CorMedix?
- What is CorMedix quarterly EBITDA year-on-year change?
- What is CorMedix TTM EBITDA?
- What is the all time high TTM EBITDA for CorMedix?
- What is CorMedix TTM EBITDA year-on-year change?
What is CorMedix annual EBITDA?
The current annual EBITDA of CRMD is -$46.23 M
What is the all time high annual EBITDA for CorMedix?
CorMedix all-time high annual EBITDA is -$2.99 M
What is CorMedix annual EBITDA year-on-year change?
Over the past year, CRMD annual EBITDA has changed by -$16.06 M (-53.21%)
What is CorMedix quarterly EBITDA?
The current quarterly EBITDA of CRMD is -$2.69 M
What is the all time high quarterly EBITDA for CorMedix?
CorMedix all-time high quarterly EBITDA is $3.51 M
What is CorMedix quarterly EBITDA year-on-year change?
Over the past year, CRMD quarterly EBITDA has changed by +$12.04 M (+81.74%)
What is CorMedix TTM EBITDA?
The current TTM EBITDA of CRMD is -$47.32 M
What is the all time high TTM EBITDA for CorMedix?
CorMedix all-time high TTM EBITDA is -$635.70 K
What is CorMedix TTM EBITDA year-on-year change?
Over the past year, CRMD TTM EBITDA has changed by -$1.08 M (-2.34%)